Enhanced development of Th2-like primary CD4 effectors in response to sustained exposure to limited rIL-4 in vivo

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3267-3274

  Yoshimoto, Keiko ^a   Swain, Susan L ^a   Bradley, Linda M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; KEYHOLE LIMPET HEMOCYANIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; HELPER CELL; IMMUNIZATION; MOUSE; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; TUMOR CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD4; DIFFUSION CHAMBERS, CULTURE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; FEMALE; HEMOCYANIN; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-4; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MOLLUSCA; RECOMBINANT PROTEINS; TH2 CELLS;

EID: 0029919962     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Coffman, R. L., B. W. Seymour, D. A. Lebman, D. A. Hiraki, J. A. Christiansen, J. A. Shrader, H. M. Cherwinski, H. F. S. Savelkoul, F. D. Finkelman, M. W. Bond, and T. Mosmann. 1988. The role of helper T cell products in mouse B cell differentiation. Immunol. Rev. 102:5.
2. Sher, A., A. R. Gazzinelli, I. P. Oswald, M. Clerici, M. Kullberb, E. J. Pearce, J. A. Berzofsky, T. R. Mosmann, S. L. James, H. C. Morse, and G. M. Shearer. 1992. Role of T cell-derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:183.
3. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
4. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
5. + subsets during murine Leishmania major infection. Res. Immunol. 142:28.
6. Finkelman, F. D., E. J. Pearch, J. J. Urban, and A. Sher. 1991. Regulation and biological function of helminth-induced cytokine responses. Immunol. Today 12:A62.
7. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.
8. Hsieh, C. S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype by interleukins 4 and 10 in an αβ T cell receptor transgenic system. Proc. Natl. Acad. Sci. USA 89:6065.
9. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
10. + cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
11. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24:793.
12. Swain, S. L., L. M. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A. D. Weinberg, D. D. Duncan, S. M. Hedrick, R. W. Dutton, and G. Huston. 1991. Helper T cell subsets: phenotype, function, and the role of lymphokines in regulating their development. Immunol. Rev. 123:115.
13. Tanaka, T., J. Hu-Li, R. A. Seder, B. Fazekas de St. Groth, and W. E. Paul. 1993. Interleukin-4 suppresses interleukin-2 and interferon-γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Natl. Acad. Sci. USA 90:5914.
14. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
15. + T cells. Eur. J. Immunol. 24:343.
16. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
17. Kamogawa, Y., L. E. Minasi, S. R. Carding, K. Bottomly, and R. A. Flavell. 1993. The relationship of IL-4 and IFN-γ-producing T cells studied by ablation of IL-4-producing cells. Cell 75:985.
18. - helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4 and interferon-γ. J. Exp. Med. 174:547.
19. Rocken, M. J., J. Urban, and E. M. Shevach. 1994. Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J. Exp. Med. 179:1885.
20. + T cell subsets in regulation of parasite immunity and disease. Immunol. Rev. 112:161.
21. Bradley, L. M., S. R. Watson, and S. L. Swain. 1994. Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J. Exp. Med. 180:2401.
22. Swain, S. L. 1994. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1:543.
23. Golumbek, P. T., R. Azhari, E. M. Jaffee, H. I. Levitsky, A. Lazenby, K. Leong, and D. M. Pardoll. 1993. Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design. Cancer Res. 53:5841.
24. Tani, K., K. Ozawa, H. Ogura, T. Takahashi, A. Okano, K. Watari, T. Matsudaira, K. Tajika, H. Karasuyama, S. Nagata, S. Asano, and F. Takaku. 1989. Implantation of fibroblasts transfected with human granulocyte colony-stimulating factor cDNA into mice as a model of cytokine-supplement gene therapy. Blood 74:1274.
25. Hladik, F., J. A. Tratkiewicz, H. Tilg, W. Vogel, U. Schwulera, M. Kronke, W. E. Aulitzky, and C. Huber. 1994. Biologic activity of low dosage IL-2 treatment in vivo: molecular assessment of cytokine network interaction. J. Immunol. 153:1449.
26. Bosco, M., M. Giovarelli, M. Forni, A. Modesti, S. Scarpa, L. Masuelli, and G. Forni. 1990. Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J. Immunol. 145:3136.
27. Finkelman, F. D., K. B. Madden, S. C. Morris, J. M. Holmes, N. Boiani, I. M. Katona, and C. R. Maliszewski. 1993. Anti-cytokine antibodies as carrier proteins: prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol. 151:1235.
28. Fearon, E. R., D. M. Pardoll, T. Itaya, P. Golumbek, H. I. Levitsky, J. W. Simons, H. Karasuyama, B. Vogelstein, and P. Frost. 1990. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397.
29. Golumbek, P. T., A. J. Lazenby, H. I. Levitsky, L. M. Jaffee, H. Karasuyama, M. Baker, and D. M. Pardoll. 1991. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713.
30. Pardoll, D. M. 1993. New strategies for enhancing the immunogenicity of tumors. Curr. Opin. Immunol. 5:719.
31. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, 5 using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
32. Swain, S. L., G. Dennert, J. Warner, and R. W. Dutton. 1981. Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen. Proc. Natl. Acad. Sci. USA 78:2517.
33. Waldman, H. S., S. Cobbold, and I. Lefkovits. 1987. Limiting dilution analysis. In Lymphocytes, A Practical Approach. G. G. B. Klaus, ed. IRL Press, Ltd., Oxford, England, p. 163.
34. + T cells: influence of antigen concentration and antigen-presenting cell type. J. Immunol. 149:3468.
35. + T cells. Annu. Rev. Immunol. 12:635.
36. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458.
37. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R. C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90:3539.
38. Raz, E., A. Watanabe, S. M. Baird, R. A. Eisenberg, T. B. Park, M. Lotz, T. J. Kipps, and D. A. Carson. 1993. Systemic immunological effects of cytokine genes injected into skeletal muscle. J. Immunol. 90:4523.
39. Lotze, M. T., L. W. Frana, S. O. Sharrow, R. J. Robb, and S. A. Rosenberg. 1985. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. J. Immunol. 134:157.
40. Ben-Sasson, S. Z., G. Le Gros, D. H. Conrad, and F. D. Finkelman. 1990. IL-4 production by T cells from naive donors: IL-2 is required for IL-4 production. J. Immunol. 145:1127.
41. Le Gros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921.
42. Hsieh, C.-S., S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713.
43. Bradley, L. M., D. D. Duncan, K. Yoshimoto, and S. L. Swain. 1993. Memory effectors: a potent, IL-4-secreting population that develops in vivo after restimulation with antigen. J. Immunol. 150:3119.
44. McHeyzer-Williams, M. G., and M. M. Davis. 1995. Antigen-specific development of primary and memory T cells in vivo. Science 268:106.
45. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
46. Croft, M., and S. L. Swain. 1995. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J. Immunol. 154:4269.